Results 181 to 190 of about 645,718 (276)

Field Study of the Prophylactic Value of Pertussis Vaccine

open access: green, 1942
James E. Perkins   +4 more
openalex   +2 more sources

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization. [PDF]

open access: yesFront Immunol, 2023
Yount KS   +11 more
europepmc   +1 more source

Maternal Pertussis Immunization and Immunoglobulin G Levels in Early- to Late-Term and Preterm Infants [PDF]

open access: yes
Importance: Maternal tetanus, diphtheria, and acellular pertussis (Tdap) vaccination protects newborns against severe pertussis. Data on transplacental antibody transfer on Tdap vaccination before 24 weeks' gestation remain scarce and are particularly ...
Dutch Maternal Pertussis Vaccine Investigation Group
core  

Heterogeneous population and its resilience to misinformation in vaccination uptake: A dual ODE and network approach [PDF]

open access: yesarXiv
Misinformation about vaccination poses a significant public health threat by reducing vaccination rates and increasing disease burden. Understanding population heterogeneity can aid in recognizing and mitigating the effects of such misinformation, especially when vaccine effectiveness is low.
arxiv  

Pertussis Vaccine in COPD and Asthma: An Old Acquaintance Is Back. [PDF]

open access: yesOpen Respir Arch, 2022
Villar-Álvarez F   +2 more
europepmc   +1 more source

Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice

open access: yesnpj Vaccines
Acellular multivalent vaccines for pertussis (DTaP and Tdap) prevent symptomatic disease and infant mortality, but immunity to Bordetella pertussis infection wanes significantly over time resulting in cyclic epidemics of pertussis.
M. Allison Wolf   +22 more
doaj   +1 more source

Home - About - Disclaimer - Privacy